Otsuka Holdings Co., Ltd. (OTSKF)
OTSKF Stock Price Chart
Explore Otsuka Holdings Co., Ltd. interactive price chart. Choose custom timeframes to analyze OTSKF price movements and trends.
OTSKF Company Profile
Discover essential business fundamentals and corporate details for Otsuka Holdings Co., Ltd. (OTSKF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
3 Aug 2012
Employees
35.34K
Website
https://www.otsuka.comCEO
Makoto Inoue
Description
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a conditioning beverage; EQUELLE and EQUELLE Gelée, which supports women's health and beauty; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; and OS-1, an oral rehydration solution. In addition, the company offers soft drinks, food products, and wines; clinical testing and medical equipment; cosmetics; warehousing and transport services; chemical products; travel agency services; analysis and measurement equipment; pharmaceutical intermediates; testing equipment, such as vehicle headlight testers; synthetic resin molded products; venture capital services; paper products; artificial turf; ceramic boards, ceramic board masterpiece arts, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; IT solution services; insecticides and toiletry products; and flaky titanate and special compounds. Further, it provides infusion and clinical nutrition products; Xenotransplantation products; hydrazine; plant-based food products, including cheese alternatives, dressings, and desserts; stable isotopes; software and services to enhance management of mental healthcare systems; products for urinary tract health; potassium titanate; bio-pesticides; functional and dietetic foods; spring and mineral water; industrial chemicals; polyolefin foams; anticancer drugs; and adhesive tapes. Additionally, the company operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
OTSKF Financial Timeline
Browse a chronological timeline of Otsuka Holdings Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 12 Feb 2026
Upcoming earnings on 31 Oct 2025
Revenue estimate is $4.29B.
Earnings released on 31 Jul 2025
EPS came in at $1.16 surpassing the estimated $1.04 by +11.54%, while revenue for the quarter reached $4.15B , beating expectations by +0.01%.
Earnings released on 30 Apr 2025
EPS came in at $1.06 surpassing the estimated $0.78 by +35.72%, while revenue for the quarter reached $3.89B , missing expectations by -8.27%.
Dividend declared on 14 Feb 2025
A dividend of $0.46 per share was announced, adjusted to $0.46. The dividend will be paid on 1 Mar 2026.
Dividend declared on 14 Feb 2025
A dividend of $0.49 per share was announced, adjusted to $0.49. The dividend was paid on 1 Sept 2025.
Earnings released on 12 Feb 2025
EPS came in at $1.78 surpassing the estimated $0.82 by +117.60%, while revenue for the quarter reached $3.81B , beating expectations by +10.44%.
Dividend declared on 27 Dec 2024
A dividend of $0.38 per share was announced, adjusted to $0.38. The dividend was paid on 31 Mar 2025.
Earnings released on 31 Oct 2024
EPS came in at $1.08 falling short of the estimated $1.30 by -16.92%, while revenue for the quarter reached $4.32B , beating expectations by +2.03%.
Earnings released on 31 Jul 2024
EPS came in at $0.35 surpassing the estimated $0.21 by +69.20%, while revenue for the quarter reached $3.67B , beating expectations by +2.32%.
Earnings released on 30 Apr 2024
EPS came in at $0.94 surpassing the estimated $0.79 by +18.99%, while revenue for the quarter reached $3.42B , beating expectations by +4.76%.
Earnings released on 14 Feb 2024
EPS came in at -$0.53 falling short of the estimated $0.46 by -215.98%, while revenue for the quarter reached $3.86B , beating expectations by +6.36%.
Dividend declared on 14 Feb 2024
A dividend of $0.38 per share was announced, adjusted to $0.38. The dividend was paid on 31 Mar 2025.
Dividend declared on 14 Feb 2024
A dividend of $0.37 per share was announced, adjusted to $0.37. The dividend was paid on 2 Sept 2024.
Earnings released on 30 Sept 2023
EPS came in at $0.73 surpassing the estimated $0.56 by +31.35%, while revenue for the quarter reached $3.56B , beating expectations by +11.94%.
Earnings released on 30 Jun 2023
EPS came in at $0.53 falling short of the estimated $0.54 by -1.87%, while revenue for the quarter reached $3.45B , beating expectations by +9.35%.
Earnings released on 31 Mar 2023
EPS came in at $0.85 surpassing the estimated $0.50 by +70.83%, while revenue for the quarter reached $3.38B , beating expectations by +9.64%.
Dividend declared on 14 Feb 2023
A dividend of $0.43 per share was announced, adjusted to $0.35. The dividend was paid on 29 Mar 2024.
Dividend declared on 14 Feb 2023
A dividend of $0.35 per share was announced, adjusted to $0.35. The dividend was paid on 4 Sept 2023.
Earnings released on 13 Feb 2023
EPS came in at $0.32 surpassing the estimated $0.18 by +72.69%, while revenue for the quarter reached $3.64B , beating expectations by +6.73%.
Earnings released on 31 Oct 2022
EPS came in at $0.52 surpassing the estimated $0.50 by +3.48%, while revenue for the quarter reached $3.12B , beating expectations by +2.43%.
Earnings released on 29 Jul 2022
EPS came in at $0.64 surpassing the estimated $0.60 by +5.46%, while revenue for the quarter reached $3.19B , beating expectations by +5.55%.
Earnings released on 13 May 2022
EPS came in at $0.33 falling short of the estimated $0.53 by -37.20%, while revenue for the quarter reached $3.11B , beating expectations by +4.18%.
Dividend declared on 10 Feb 2022
A dividend of $0.38 per share was announced, adjusted to $0.37. The dividend was paid on 31 Mar 2023.
Dividend declared on 10 Feb 2022
A dividend of $0.37 per share was announced, adjusted to $0.37. The dividend was paid on 5 Sept 2022.
Earnings released on 9 Feb 2022
EPS came in at -$0.02 falling short of the estimated $0.28 by -106.84%, while revenue for the quarter reached $3.40B , beating expectations by +2.03%.
Earnings released on 11 Nov 2021
EPS came in at $0.57 falling short of the estimated $0.80 by -28.98%, while revenue for the quarter reached $3.49B .
Earnings released on 6 Aug 2021
EPS came in at $0.79 surpassing the estimated $0.70 by +12.95%, while revenue for the quarter reached $3.44B .
Earnings released on 13 May 2021
EPS came in at $0.75 surpassing the estimated $0.59 by +28.23%, while revenue for the quarter reached $3.05B .
Dividend declared on 12 Feb 2021
A dividend of $0.43 per share was announced, adjusted to $0.44. The dividend was paid on 31 Mar 2022.
Dividend declared on 12 Feb 2021
A dividend of $0.45 per share was announced, adjusted to $0.45. The dividend was paid on 6 Sept 2021.
Earnings released on 11 Feb 2021
EPS came in at $0.36 falling short of the estimated $0.40 by -11.05%, while revenue for the quarter reached $3.44B .
Earnings released on 12 Nov 2020
EPS came in at $0.72 falling short of the estimated $0.76 by -4.77%, while revenue for the quarter reached $3.52B .
Dividend declared on 14 Feb 2020
A dividend of $0.48 per share was announced, adjusted to $0.48. The dividend was paid on 31 Mar 2021.
OTSKF Stock Performance
Access detailed OTSKF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.